Who we are

GeneFerm Biotechnology is founded in 1999 by founder, Jin Wei-Min.
Gene means the code of life, contains the genetic information that constructs life;
Ferm is short for Fermentation, the process of microbial life activities and metabolites.

GeneFerm Panorama

GeneFerm act as the "Master of Microbial Fermentation", values the importance and care for human health. GeneFerm has expertise in the field of microbial fermentation for more than 30 years and also has professional R&D and mass production capabilities.
Our core technologies: strain screening, medium optimization, fermentation strategy, and relevant quantitative processes such as extraction and purification. GeneFerm has obtained many international certifications, national patents, multinational awards, and professional research.

4 Services of GeneFerm

We continue to improve existing service projects, actively develop areas related to microbial fermentation, and mass-produce diverse functional products of microorganisms through fermentation technology, reduce the use of chemicals, and paint a better picture for the sustainable development of the earth.

Toll Manufacturing

Toll Manufacturing

Microbial Fermentation Toll Manufacturing Service

Functional Ingredients

Functional Ingredients

Fermentation, extraction, probiotics and peptide raw materials

Extraction Manufacturing

Extraction Manufacturing

Optimize the extraction process with complete equipments

Private Label Supplement

Private Label Supplement

Consistent and Complete Development of Health Supplement

Vision & mission

GeneFerm adheres to the four principles of "integrity, professionalism, innovation, and service" to make a trust-worthy commitment to creating a wholesome life for people.

map
GeneFerm Biotechnology Founded
1999
  • Did the research and development of the blood lipid-lowering agent intermediate "Compactin" in the open laboratory of the Food Industry Development Institute.
  • Obtained the SBIR subsidy from the Ministry of Economic Affairs "Production Technology Innovation Project of Compactin, an Intermediate of Hypolipidemic Agent".
  • 1999
    2000
  • The R&D results surpassed the target yield of the SBIR project.
  • Built a new plant and set up two sets of 5,000L fermentation equipment at Sinying for R&D and mass production of API intermediates.
  • 2000
    2001
  • Set up Taipei Sales Department to expand domestic and foreign markets.
  • Massively produced edible and medicinal mushrooms and functional fermented products.
  • 2002
  • Shortlisted for the First Science and Technology Star Award by the Ministry of Economic Affairs.
  • 2002
    2003
  • Speedily obtained the approval of the National Science Council Review Committee to enter the Tainan Science Park.
  • Mapped out to build a high-tech factory in Tainan Science Park that complies with cGMP standards.
  • 2003
    2004
  • The plant in Tainan Science Park was completed and successfully activated 50,000L fermentation mass production equipment.
  • Obtained ISO 9001 : 2000 International Quality Certificate
  • 2004
    2005
  • Awarded as Excellent Manufacturer by the Minister of Labor Republic of China (Taiwan).
  • Obtained the "National Product Quality Gold Medal".
  • 2005
    2007
  • Obtained ISO 22000 and HACCP International Quality Certificates.
  • Co-published the research results of "Phellinus linteus: Anti-liver Fibrosis" with College of Medicine, National Cheng Kung University.
  • 20072007
    2008
  • Signed a contract with Kemin to become its Asian mass production and delivery center.
  • Cooperated with the Medical Center to verify the benefits of oral nattokinase products for patients with dyslipidemia.
  • 2008
    2009
  • Obtained the Halal certification of Islamic food, actively expand the Muslim market at home and abroad.
  • 2009
    2011
  • Established Shanghai branch.
  • Cooperated with the Medical Center to verify the effectiveness of NattoMena®, natural vitamin K2, on preventing osteoporosis and vascular calcification.
  • 2011
    2012
  • Acquired the patent of Antrodia cinnamomea mycelium liquid capsule.
  • Published the fingerprint and pharmacokinetic research of Antrodia cinnamomea studies in international journals.
  • NattoMena® gained SNQ National Quality award.
  • 20122012 2012
    2013
  • Signed a tripartite cooperation with a German biotechnology company and Food Industry Research and Development Institute to develop and mass produce key enzymes.
  • 2014
  • Cooperate with a Japanese hundred-year factory to conduct development and mass production of fermentation products.
  • 2015
  • Participated in Guan-Rong program
  • Established Dong Guan branch
  • 2016
  • Established Jiangsu branch
  • Expanded with two sets of 55,000L fermentation equipment
  • 2016
    2017
  • Expanded with three sets of drying equipment at the plant in Tainan Science Park
  • Built a filling and packaging plant that meets GHP specifications at Sinying factory
  • Obtained Dun & Bradstreet Elite SME Award
  • Awarded the honor of "Deloitte Asia-Pacific High-tech, High-growth top 500"
  • 2017
    2018
  • Officially listed on TPEx-Listed Stocks on January 22, 2018 (Stock Code: 1796)
  • Malaysian Investment Development Authority (MIDA) highly appreciates GeneFerm Biotechnology's fermentation proficiency and products.
  • Obtained NSF‐DS GMP Certificate, which is recognized by the American National Standards Institute (ANSI) and the Standard Council of Canada (SCC).
  • NattoMena® obtained Gold Award at International Innovation & Invention Competition
  • 2018
    2019
  • NattoMena® obtained two Taiwan patents
  • LABCOT® lactic acid bacteria obtained the Taiwan Patent and the Gold Medal Award of Korea WiC.
  • 37Labtico™ obtained Taiwan patent
  • 2019 2019 2019
    2020
  • Highly active nattokinase obtained the Japan patent
  • 37Labtico™ obtained China patent
  • LaLaBling™ enzyme obtained Gold Medal at IIIC
  • GSH12X™、37Labtico™ obtained three gold medals at 2020 Tokyo Invention Exhibition (GSH12X™, Dual-efficacy Polysaccharides) and 2020 Korea WiC (37Labtico™)
  • 2020 2020 2020